A detailed history of Ethic Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Ethic Inc. holds 69,767 shares of LLY stock, worth $55.5 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares
69,767
Previous 74,103 5.85%
Holding current value
$55.5 Million
Previous $67.1 Million 7.87%
% of portfolio
1.56%
Previous 1.59%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $3.35 Million - $4.16 Million
-4,336 Reduced 5.85%
69,767 $61.8 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $3.14 Million - $3.94 Million
4,336 Added 6.21%
74,103 $67.1 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $4.3 Million - $5.75 Million
7,255 Added 11.61%
69,767 $54.3 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $1.02 Million - $1.2 Million
1,940 Added 3.2%
62,512 $36.4 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $2.2 Million - $3.03 Million
5,059 Added 9.11%
60,572 $32.5 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $323,031 - $431,930
921 Added 1.69%
55,513 $26 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $1.71 Million - $2.01 Million
5,514 Added 11.24%
54,592 $18.7 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $1.94 Million - $2.26 Million
6,023 Added 13.99%
49,078 $18 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $1.74 Million - $1.98 Million
5,866 Added 15.77%
43,055 $13.9 Million
Q2 2022

Aug 10, 2022

BUY
$278.73 - $327.27 $5.93 Million - $6.96 Million
21,275 Added 133.69%
37,189 $12.1 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $2.28 Million - $2.84 Million
-9,729 Reduced 37.94%
15,914 $4.56 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $3.04 Million - $3.78 Million
13,533 Added 111.75%
25,643 $7.08 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $690,505 - $849,764
3,116 Added 34.65%
12,110 $2.8 Million
Q2 2021

Aug 10, 2021

SELL
$180.55 - $233.54 $764,809 - $989,275
-4,236 Reduced 32.02%
8,994 $2.06 Million
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $283,944 - $367,580
1,728 Added 15.02%
13,230 $2.47 Million
Q4 2020

Feb 10, 2021

BUY
$130.46 - $172.63 $314,408 - $416,038
2,410 Added 26.51%
11,502 $1.94 Million
Q3 2020

Oct 27, 2020

BUY
$146.22 - $169.13 $183,652 - $212,427
1,256 Added 16.03%
9,092 $1.35 Million
Q2 2020

Aug 12, 2020

BUY
$136.42 - $164.18 $168,342 - $202,598
1,234 Added 18.69%
7,836 $1.29 Million
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $93,335 - $115,522
784 Added 13.48%
6,602 $916,000
Q4 2019

May 22, 2020

BUY
$106.92 - $132.43 $102,857 - $127,397
962 Added 19.81%
5,818 $765,000
Q4 2019

Feb 13, 2020

BUY
$106.92 - $132.43 $519,203 - $643,080
4,856 New
4,856 $638,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ethic Inc. Portfolio

Follow Ethic Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.